Obesity and risk for chronic renal failure.

PubWeight™: 3.67‹?› | Rank: Top 1%

🔗 View Article (PMID 16641153)

Published in J Am Soc Nephrol on April 26, 2006

Authors

Elisabeth Ejerblad1, C Michael Fored, Per Lindblad, Jon Fryzek, Joseph K McLaughlin, Olof Nyrén

Author Affiliations

1: Department of Medical Epidemiology and Biostatistic, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden. elisabeth.ejerblad@meb.ki.se

Articles citing this

(truncated to the top 100)

Body mass index in 1.2 million adolescents and risk for end-stage renal disease. Arch Intern Med (2012) 2.62

Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study. Am J Kidney Dis (2008) 1.82

ACE inhibition is renoprotective among obese patients with proteinuria. J Am Soc Nephrol (2011) 1.70

Influence of race, ethnicity and socioeconomic status on kidney disease. Nat Rev Nephrol (2012) 1.67

Central body fat distribution associates with unfavorable renal hemodynamics independent of body mass index. J Am Soc Nephrol (2013) 1.62

Oxidative stress and inflammation are associated with adiposity in moderate to severe CKD. J Am Soc Nephrol (2008) 1.44

Overweight, obesity, and elevated serum cystatin C levels in adults in the United States. Am J Med (2008) 1.37

The Role of Overweight and Obesity in the Cardiorenal Syndrome. Cardiorenal Med (2011) 1.35

Association of body mass index with outcomes in patients with CKD. J Am Soc Nephrol (2014) 1.30

Evidence-based practice guideline for the treatment of CKD. Clin Exp Nephrol (2009) 1.29

The enlarging body of evidence: obesity and chronic kidney disease. J Am Soc Nephrol (2006) 1.22

Etiopathology of chronic tubular, glomerular and renovascular nephropathies: clinical implications. J Transl Med (2011) 1.18

Renal biopsy in the very elderly. Clin J Am Soc Nephrol (2009) 1.15

A population-based survey of Chronic REnal Disease In Turkey--the CREDIT study. Nephrol Dial Transplant (2010) 1.13

Nebivolol attenuates redox-sensitive glomerular and tubular mediated proteinuria in obese rats. Endocrinology (2010) 1.03

Obesity indices and adipokines in non-diabetic obese patients with early stages of chronic kidney disease. Med Sci Monit (2013) 1.01

Anthropomorphic measurements that include central fat distribution are more closely related with key risk factors than BMI in CKD stage 3. PLoS One (2012) 1.01

Diabetic nephropathy and its risk factors in a society with a type 2 diabetes epidemic: a Saudi National Diabetes Registry-based study. PLoS One (2014) 1.00

Changes in body weight predict CKD in healthy men. J Am Soc Nephrol (2008) 0.99

Adipose tissue immune response: novel triggers and consequences for chronic inflammatory conditions. Inflammation (2014) 0.98

Obesity in CKD--what should nephrologists know? J Am Soc Nephrol (2013) 0.98

The link between the renin-angiotensin-aldosterone system and renal injury in obesity and the metabolic syndrome. Curr Hypertens Rep (2012) 0.97

Obesity and diabetic kidney disease. Med Clin North Am (2012) 0.97

Obesity, metabolic health, and the risk of end-stage renal disease. Kidney Int (2014) 0.95

Acute kidney injury, renal function, and the elderly obese surgical patient: a matched case-control study. Ann Surg (2013) 0.94

Renal function and sleep-disordered breathing in older men. Nephrol Dial Transplant (2008) 0.93

Hypertension and low HDL cholesterol were associated with reduced kidney function across the age spectrum: a collaborative study. Ann Epidemiol (2013) 0.90

Chronic kidney disease in Nicaragua: a qualitative analysis of semi-structured interviews with physicians and pharmacists. BMC Public Health (2013) 0.90

Association of sarcopenia with eGFR and misclassification of obesity in adults with CKD in the United States. Clin J Am Soc Nephrol (2014) 0.90

End-stage renal disease and low level exposure to lead, cadmium and mercury; a population-based, prospective nested case-referent study in Sweden. Environ Health (2013) 0.89

The incidence of albuminuria after bariatric surgery and usual care in Swedish Obese Subjects (SOS): a prospective controlled intervention trial. Int J Obes (Lond) (2014) 0.89

Change in prevalence of chronic kidney disease in England over time: comparison of nationally representative cross-sectional surveys from 2003 to 2010. BMJ Open (2014) 0.89

Physiological and management implications of obesity in critical illness. Ann Am Thorac Soc (2014) 0.88

Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease. Nat Rev Nephrol (2015) 0.88

Measuring the glomerular filtration rate in obese individuals without overt kidney disease. Nephron Clin Pract (2010) 0.88

Physical Activity in the Prevention of Chronic Kidney Disease. Cardiorenal Med (2011) 0.87

Can genetic pleiotropy replicate common clinical constellations of cardiovascular disease and risk? PLoS One (2012) 0.87

Interaction of aldosterone and extracellular volume in the pathogenesis of obesity-associated kidney disease: a narrative review. Am J Nephrol (2009) 0.87

Creatinine-Based and Cystatin C-Based GFR Estimating Equations and Their Non-GFR Determinants in Kidney Transplant Recipients. Clin J Am Soc Nephrol (2016) 0.87

Implications for kidney disease in obese children and adolescents. Pediatr Nephrol (2011) 0.87

Obesity and the Cardiorenal Metabolic Syndrome: Therapeutic Modalities and Their Efficacy in Improving Cardiovascular and Renal Risk Factors. Cardiorenal Med (2012) 0.86

Protein-energy malnutrition during early gestation in sheep blunts fetal renal vascular and nephron development and compromises adult renal function. J Physiol (2011) 0.86

Metabolic syndrome, insulin resistance and kidney function in non-diabetic individuals. Nephrol Dial Transplant (2011) 0.85

Decreased body mass index as an independent risk factor for developing chronic kidney disease. Clin Exp Nephrol (2008) 0.85

Risk factors for chronic kidney disease: an update. Kidney Int Suppl (2011) (2013) 0.84

Obesity and impaired renal function: potential for lifestyle intervention? Eur J Epidemiol (2009) 0.84

Pathological influence of obesity on renal structural changes in chronic kidney disease. Clin Exp Nephrol (2009) 0.84

Obesity in kidney disease: A heavyweight opponent. World J Nephrol (2014) 0.84

The role of novel biomarkers of cardiovascular disease in chronic kidney disease: focus on adiponectin and leptin. Curr Cardiol Rev (2008) 0.83

The risk of chronic kidney disease in a metabolically healthy obese population. Kidney Int (2015) 0.83

U-shaped association between central body fat and the urinary albumin-to-creatinine ratio and microalbuminuria. BMC Nephrol (2013) 0.83

The association between uric acid and chronic kidney disease in Korean men: a 4-year follow-up study. J Korean Med Sci (2013) 0.83

Obese patients in an open MRI at 1.0 Tesla: image quality, diagnostic impact and feasibility. Eur Radiol (2010) 0.83

Metabolic imaging of human kidney triglyceride content: reproducibility of proton magnetic resonance spectroscopy. PLoS One (2013) 0.83

The association of retinopathy and low GFR in type 2 diabetes. Diabetes Res Clin Pract (2012) 0.82

Overnutrition and the Cardiorenal Syndrome: Use of a Rodent Model to Examine Mechanisms. Cardiorenal Med (2011) 0.82

Body mass index and metabolic factors predict glomerular filtration rate and albuminuria over 20 years in a high-risk population. BMC Nephrol (2013) 0.82

Kidney function in severely obese adolescents undergoing bariatric surgery. Obesity (Silver Spring) (2014) 0.82

Occupational factors associated with changes in the body mass index of korean male manual workers. Ann Occup Environ Med (2013) 0.81

Autophagy and metabolic changes in obesity-related chronic kidney disease. Nephrol Dial Transplant (2013) 0.81

Hypertriglyceridemic waist phenotype and chronic kidney disease in a Chinese population aged 40 years and older. PLoS One (2014) 0.81

Is obesity a risk factor for chronic kidney disease in children? Pediatr Nephrol (2012) 0.80

Relationship between changes in body fat and a decline of renal function in the elderly. PLoS One (2014) 0.80

Safety analysis of primary bariatric surgery in patients on chronic dialysis. Surg Endosc (2015) 0.80

Sarcopenia, obesity, and mortality in US adults with and without chronic kidney disease. KI Rep (2016) 0.80

Cardiometabolic risk profiles associated with chronic complications in overweight and obese type 2 diabetes patients in South China. PLoS One (2014) 0.79

Clinical epidemiology of reduced kidney function among elderly male fishing and agricultural population in Taipei, Taiwan. Biomed Res Int (2013) 0.79

Race modifies the association between adiposity and inflammation in patients with chronic kidney disease: findings from the chronic renal insufficiency cohort study. Obesity (Silver Spring) (2014) 0.79

Obesity: an independent predictor of in-hospital postoperative renal insufficiency among patients undergoing cardiac surgery? Tex Heart Inst J (2009) 0.79

Analysis of renal functions and proteinuria in young obese adults. J Endocrinol Invest (2015) 0.78

Obesity increases the risk of end-stage renal disease among living kidney donors. Kidney Int (2016) 0.78

Association of Body Mass Index with Clinical Outcomes in Non-Dialysis-Dependent Chronic Kidney Disease: A Systematic Review and Meta-Analysis. Cardiorenal Med (2015) 0.78

Metabolic syndrome in children with chronic kidney disease and after renal transplantation. Pediatr Nephrol (2013) 0.78

Metabolic syndrome and its components associated with chronic kidney disease. J Res Med Sci (2015) 0.78

Increased body fat rather than body weight has harmful effects on 4-year changes of renal function in the general elderly population with a normal or mildly impaired renal function. Clin Interv Aging (2014) 0.78

Obesity and heart failure as a mediator of the cerebrorenal interaction. Contrib Nephrol (2013) 0.78

Short- and Long-Term Mortality Rates of Elderly Acute Kidney Injury Patients Who Underwent Continuous Renal Replacement Therapy. PLoS One (2016) 0.78

Proteinuria and decreased body mass index as a significant risk factor in developing end-stage renal disease. Clin Exp Nephrol (2008) 0.77

Obesity is associated with race/sex disparities in diabetes and hypertension prevalence, but not cardiovascular disease, among HIV-infected adults. AIDS Res Hum Retroviruses (2015) 0.77

FTO modulates fibrogenic responses in obstructive nephropathy. Sci Rep (2016) 0.77

Blood pressure and diabetic nephropathy. Diabetes Care (2010) 0.76

Resistance to insulin and kidney disease in the cardiorenal metabolic syndrome; role for angiotensin II. Mol Cell Endocrinol (2013) 0.76

The impact of insulin resistance on the kidney and vasculature. Nat Rev Nephrol (2016) 0.75

Higher glomerular filtration rate is related to insulin resistance but not to obesity in a predominantly obese non-diabetic cohort. Sci Rep (2017) 0.75

Increased body mass index may be associated with greater risk of end-stage renal disease in whites compared to blacks: A nested case-control study. BMC Nutr (2015) 0.75

Comparison of methods for renal risk prediction in patients with type 2 diabetes (ZODIAC-36). PLoS One (2015) 0.75

An Analysis of Anthropometric Indicators and Modifiable Lifestyle Parameters Associated with Hypertensive Nephropathy. Int J Hypertens (2016) 0.75

Neck circumference predicts renal function decline in overweight women: A community-based prospective cohort study. Medicine (Baltimore) (2016) 0.75

Treatment strategies to prevent renal damage in hypertensive children. Curr Hypertens Rep (2014) 0.75

Effects of Direct Renin Blockade on Renal & Systemic Hemodynamics and on RAAS Activity, in Weight Excess and Hypertension: A Randomized Clinical Trial. PLoS One (2017) 0.75

Early development of podocyte injury independently of hyperglycemia and elevations in arterial pressure in nondiabetic obese Dahl SS leptin receptor mutant rats. Am J Physiol Renal Physiol (2016) 0.75

Obesity and kidney disease: Hidden consequences of the epidemic. Indian J Nephrol (2017) 0.75

The Obesity Paradox and the Role of Inflammation. J Am Soc Nephrol (2015) 0.75

World Congress on the Insulin Resistance Syndrome, 2009: the kidney, the liver, and insulin resistance. Diabetes Care (2010) 0.75

Obesity and the response to intensified diuretic treatment in decompensated heart failure: a DOSE trial substudy. J Card Fail (2012) 0.75

Adiposity patterns and the risk for ESRD in postmenopausal women. Clin J Am Soc Nephrol (2014) 0.75

Combined body mass index with high-sensitivity C-reactive protein as independent predictors for chronic kidney disease in a relatively healthy population in Taiwan. Eur J Clin Nutr (2016) 0.75

Anthropometric and Metabolic Risk Factors for ESRD Are Disease-Specific: Results from a Large Population-Based Cohort Study in Austria. PLoS One (2016) 0.75

The Envy of Scholars: Applying the Lessons of the Framingham Heart Study to the Prevention of Chronic Kidney Disease. Rambam Maimonides Med J (2015) 0.75

Obesity and renovascular disease. Am J Physiol Renal Physiol (2015) 0.75

Articles by these authors

The false-positive to false-negative ratio in epidemiologic studies. Epidemiology (2011) 4.93

The epidemiology of renal cell carcinoma. J Urol (2006) 3.85

Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study. Lancet (2007) 3.84

False-positive results in cancer epidemiology: a plea for epistemological modesty. J Natl Cancer Inst (2008) 3.72

Southern community cohort study: establishing a cohort to investigate health disparities. J Natl Med Assoc (2005) 3.67

Cancer risk among statin users: a population-based cohort study. Int J Cancer (2005) 3.50

'Environment' in cancer causation and etiological fraction: limitations and ambiguities. Carcinogenesis (2007) 3.20

Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort. Environ Health Perspect (2007) 3.03

Risk of cancer after blood transfusion from donors with subclinical cancer: a retrospective cohort study. Lancet (2007) 3.00

Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment? Arthritis Rheum (2009) 2.97

Characteristics of US patients with myelodysplastic syndromes: results of six cross-sectional physician surveys. J Natl Cancer Inst (2008) 2.64

Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J Natl Cancer Inst (2004) 2.63

Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists. Ann Rheum Dis (2007) 2.53

Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden. Arthritis Rheum (2005) 2.45

A further plea for adherence to the principles underlying science in general and the epidemiologic enterprise in particular. Int J Epidemiol (2009) 2.35

Cellular telephone use and cancer risk: update of a nationwide Danish cohort. J Natl Cancer Inst (2006) 2.33

Comparing diabetes prevalence between African Americans and Whites of similar socioeconomic status. Am J Public Health (2007) 2.24

Review of epidemiologic studies of dietary acrylamide intake and the risk of cancer. Eur J Cancer Prev (2012) 2.19

A rebuttal: secret ties to industry and conflicting interests in cancer research. Am J Ind Med (2007) 1.99

Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study. Arch Intern Med (2005) 1.98

The natural history of chronic renal failure: results from an unselected, population-based, inception cohort in Sweden. Am J Kidney Dis (2005) 1.97

Confounding by indication in epidemiologic studies of commonly used analgesics. Am J Ther (2002) 1.82

Cancer incidence in patients with type 1 diabetes mellitus: a population-based cohort study in Sweden. J Natl Cancer Inst (2003) 1.79

Risk factors for long-term pain after hernia surgery. Ann Surg (2006) 1.74

A cohort mortality study among titanium dioxide manufacturing workers in the United States. J Occup Environ Med (2003) 1.70

Molecular epidemiology of VHL gene mutations in renal cell carcinoma patients: relation to dietary and other factors. Carcinogenesis (2002) 1.68

A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus. Nat Genet (2013) 1.67

Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium. J Natl Cancer Inst (2010) 1.60

Maternal caffeine consumption and spontaneous abortion: a review of the epidemiologic evidence. Epidemiology (2004) 1.57

A cohort study of antihypertensive medication use and breast cancer among Danish women. Breast Cancer Res Treat (2006) 1.57

Maternal levels of perfluorinated chemicals and subfecundity. Hum Reprod (2009) 1.56

Meat intake and risk of stomach and esophageal adenocarcinoma within the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst (2006) 1.55

Risk of gastric cancer and peptic ulcers in relation to ABO blood type: a cohort study. Am J Epidemiol (2010) 1.54

Duration of red blood cell storage and survival of transfused patients (CME). Transfusion (2010) 1.53

Lung cancer risk among smokers of menthol cigarettes. J Natl Cancer Inst (2011) 1.50

Reconstructive breast implantation after mastectomy for breast cancer: clinical outcomes in a nationwide prospective cohort study. Arch Surg (2005) 1.43

Smoking and the risk of gastric cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). Int J Cancer (2003) 1.42

Baseline characteristics and predictors of outcome in patients with myelodysplastic syndromes living in Western Pennsylvania. Leuk Lymphoma (2011) 1.42

Socio-economic status and chronic renal failure: a population-based case-control study in Sweden. Nephrol Dial Transplant (2003) 1.41

Helicobacter pylori eradication has the potential to prevent gastric cancer: a state-of-the-art critique. Am J Gastroenterol (2005) 1.40

Nonaspirin nonsteroidal anti-inflammatory drugs and risk of hospitalization for intracerebral hemorrhage: a population-based case-control study. Stroke (2003) 1.40

A global assessment of the oesophageal adenocarcinoma epidemic. Gut (2012) 1.40

Prevalence of symptomatic pelvic organ prolapse in a Swedish population. Int Urogynecol J Pelvic Floor Dysfunct (2005) 1.39

Do cosmetic breast implants cause suicide? Plast Reconstr Surg (2003) 1.39

The diagnosis of silicone breast-implant rupture: clinical findings compared with findings at magnetic resonance imaging. Ann Plast Surg (2005) 1.38

Silicone breast implants. J Rheumatol (2004) 1.37

Fetal growth indicators and perfluorinated chemicals: a study in the Danish National Birth Cohort. Am J Epidemiol (2008) 1.33

Breast implants and lymphoma risk: a review of the epidemiologic evidence through 2008. Plast Reconstr Surg (2009) 1.31

Dietary factors and risk of colon cancer in Shanghai, China. Cancer Epidemiol Biomarkers Prev (2003) 1.31

Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium. Int J Epidemiol (2012) 1.30

Incidence and predictors of end stage renal disease among low-income blacks and whites. PLoS One (2012) 1.29

Are women more susceptible to lung cancer? J Natl Cancer Inst (2004) 1.27

Macrolide resistance in the normal microbiota after Helicobacter pylori treatment. Scand J Infect Dis (2007) 1.27

Obesity and all-cause mortality among black adults and white adults. Am J Epidemiol (2012) 1.26

Aspirin and other non-steroidal anti-inflammatory drugs and risk of colorectal cancer: a Danish cohort study. Cancer Causes Control (2009) 1.25

Cancer risk among workers at Danish companies using trichloroethylene: a cohort study. Am J Epidemiol (2003) 1.23

Use of electronic medical records in oncology outcomes research. Clinicoecon Outcomes Res (2010) 1.21

Elevated hip fracture risk in type 1 diabetic patients: a population-based cohort study in Sweden. Diabetes Care (2005) 1.20

Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database. Br J Haematol (2009) 1.19

The diagnosis of breast implant rupture: MRI findings compared with findings at explantation. Eur J Radiol (2005) 1.19

Surgical intervention and capsular contracture after breast augmentation: a prospective study of risk factors. Ann Plast Surg (2005) 1.19

Alcohol intake and risk of oesophageal adenocarcinoma: a pooled analysis from the BEACON Consortium. Gut (2011) 1.18

Cancer risk in persons receiving prescriptions for paracetamol: a Danish cohort study. Int J Cancer (2002) 1.18

Incidence of silicone breast implant rupture. Arch Surg (2003) 1.18

CagA+ Helicobacter pylori infection and gastric cancer risk in the EPIC-EURGAST study. Int J Cancer (2007) 1.18

Psychosocial working conditions and the risk of esophageal and gastric cardia cancers. Eur J Epidemiol (2004) 1.18

Nonsteroidal anti-inflammatory drug use and breast cancer risk: a Danish cohort study. Eur J Cancer Prev (2008) 1.18

Nonobstetric risk factors for symptomatic pelvic organ prolapse. Obstet Gynecol (2009) 1.17

Prenatal exposure to perfluorooctanoate (PFOA) and perfluorooctanesulfonate (PFOS) and maternally reported developmental milestones in infancy. Environ Health Perspect (2008) 1.17

Flavonoids and the risk of renal cell carcinoma. Cancer Epidemiol Biomarkers Prev (2007) 1.16

Risk factors for Barrett's oesophagus: a population-based approach. Scand J Gastroenterol (2007) 1.16

Devastating injuries in healthcare workers: description of the crisis and legislative solution to the epidemic of back injury from patient lifting. J Long Term Eff Med Implants (2005) 1.15

Survival after blood transfusion. Transfusion (2008) 1.14

Socioeconomic factors and risk of esophageal adenocarcinoma: a nationwide Swedish case-control study. Cancer Epidemiol Biomarkers Prev (2005) 1.14

Epidemiology of renal cell cancer. Hematol Oncol Clin North Am (2011) 1.14

Racial differences in serum cotinine levels of smokers. Dis Markers (2009) 1.13

Association between smoking and chronic renal failure in a nationwide population-based case-control study. J Am Soc Nephrol (2004) 1.13

Pattern of declining hemoglobin concentration before cancer diagnosis. Int J Cancer (2010) 1.13

Prostate carcinoma risk subsequent to diagnosis of benign prostatic hyperplasia: a population-based cohort study in Sweden. Cancer (2003) 1.13

Risks of nontraumatic lower-extremity amputations in patients with type 1 diabetes: a population-based cohort study in Sweden. Diabetes Care (2008) 1.12

SMS versus telephone interviews for epidemiological data collection: feasibility study estimating influenza vaccination coverage in the Swedish population. Eur J Epidemiol (2008) 1.11

Antidepressants and risk of first-time hospitalization for myocardial infarction: a population-based case-control study. Am J Med (2004) 1.10

Risk of esophageal adenocarcinoma in achalasia patients, a retrospective cohort study in Sweden. Am J Gastroenterol (2011) 1.10

Incidence of breast and other cancers among Finnish women with cosmetic breast implants, 1970-1999. J Long Term Eff Med Implants (2002) 1.08

Upper gastrointestinal bleeding among users of NSAIDs: a population-based cohort study in Denmark. Br J Clin Pharmacol (2002) 1.08

Risk of gastroesophageal cancer among smokers and users of Scandinavian moist snuff. Int J Cancer (2008) 1.07

The XPD 751Gln allele is associated with an increased risk for esophageal adenocarcinoma: a population-based case-control study in Sweden. Carcinogenesis (2006) 1.07

Dietary intake of heterocyclic amines and cancers of the esophagus and gastric cardia. Cancer Epidemiol Biomarkers Prev (2003) 1.06

Validity and reliability of self-reported total energy expenditure using a novel instrument. Eur J Epidemiol (2006) 1.05

Cancer and mortality among users and nonusers of snus. Int J Cancer (2008) 1.05

Epidemiological investigation of local complications after cosmetic breast implant surgery in Denmark. Ann Plast Surg (2002) 1.04